Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the efficacy of lebrikizumab compared with placebo in improving lung function, as measured by the absolute change in pre-bronchodilator forced expiratory volume in one second (FEV1) in patients with COPD and a history of exacerbations in the biomarker-high group (elevated serum periostin and blood eosinophils) and biomarker low group.
Inclusion criteria
- Chronic Obstructive Pulmonary Disease (COPD)